Howard McLeod, PharmD, a professor at the UNC School of Pharmacy and the director of the UNC Institute for Pharmacogenomics and Individualized Therapy, has been selected to deliver the 2008 Dr. William B. Abrams Lecture, becoming the first PharmD scientist … Read more
Not everyone needs a genetic test before taking the cancer drug irinotecan, and the U.S. Food and Drug Administration should modify its prescription guidelines to say so, according to researchers at the University of North Carolina at Chapel Hill. Irinotecan, … Read more
The Institute for Pharmacogenomics and Individualized Therapy at the University of North Carolina at Chapel Hill presented its 2007 awards at the Second Annual Chapel Hill Drug Conference on May 19. Janet Woodcock, MD, chief medical officer of the Food … Read more
New Pharmacy Professor Seeks to Match the Medicine to the Patient Howard McLeod, PharmD, wants to help physicians get it right the first time when they select a medicine to treat cancer and other illnesses. He is heading a new … Read more
Howard McLeod, PharmD, formerly of Washington University in St. Louis, has been appointed the Fred Eshelman Distinguished Professor in the Division of Pharmacotherapy and Experimental Therapeutics at the UNC School of Pharmacy. He is also the director of the new … Read more
